1FJ1 image
Deposition Date 2000-08-07
Release Date 2000-10-11
Last Version Date 2024-11-13
Entry Detail
PDB ID:
1FJ1
Keywords:
Title:
LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.68 Å
R-Value Free:
0.28
R-Value Work:
0.22
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HYBRIDOMA ANTIBODY LA2 (LIGHT CHAIN)
Chain IDs:A, C
Chain Length:213
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:HYBRIDOMA ANTIBODY LA2 (HEAVY CHAIN)
Chain IDs:B, D
Chain Length:213
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:OUTER SURFACE PROTEIN A
Chain IDs:E, F
Chain Length:257
Number of Molecules:2
Biological Source:Borrelia burgdorferi
Primary Citation
Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
J.Mol.Biol. 302 1153 1164 (2000)
PMID: 11183781 DOI: 10.1006/jmbi.2000.4119

Abstact

Outer surface protein A (OspA) is a major lipoprotein of the Borrelia burgdorferi spirochete, the causative agent of Lyme disease. Vaccination with OspA generates an immune response that can prevent bacterial transmission to a mammalian host during the attachment of an infected tick. However, the protective capacity of immune sera cannot be predicted by measuring total anti-OspA antibody. The murine monoclonal antibody LA-2 defines an important protective B-cell epitope of OspA against which protective sera have strong levels of reactivity. We have now mapped the LA-2 epitope of OspA using both NMR chemical-shift perturbation measurements in solution and X-ray crystal structure determination. LA-2 recognizes the three surface-exposed loops of the C-terminal domain of OspA that are on the tip of the elongated molecule most distant from the lipid-modified N terminus. The structure suggests that the natural variation at OspA sequence position 208 in the first loop is a major limiting factor for antibody cross-reactivity between different Lyme disease-causing Borrelia strains. The unusual Fab-dominated lattice of the crystal also permits a rare view of antigen flexibility within an antigen:antibody complex. These results provide a rationale for improvements in OspA-based vaccines and suggest possible designs for more direct tests of antibody protective levels in vaccinated individuals.

Legend

Protein

Chemical

Disease

Primary Citation of related structures